NASDAQ, CLDX - Celldex Therapeutics
As used herein, the terms "we," "us," "our," or "AVANT" refer to AVANT
Immunotherapeutics, Inc., a Delaware corporation organized in 1983 and its
subsidiaries. We are a biopharmaceutical company that uses novel applications of
immunology to develop products for the prevention and treatment of diseases. We
are developing a broad portfolio of vaccines and immunotherapeutics addressing a
wide range of applications including bacterial diseases, food safety and
cardiovascular disease. These include single-dose, oral vaccines that protect
against important disease-causing infectious agents, a treatment to reduce
complement-mediated tissue damage and a novel, proprietary vaccine candidate for
cholesterol management. Our strategy is to demonstrate proof-of-concept for our
product candidates before leveraging their value through partnerships or, in
appropriate situations, continuing late stage development ourselves. ...
Read SEC Filing on NASDAQ.com »